bpc 157 dosing oral bpc-157 protocol human BPC-157 Dosing (Common Protocols) πΉ / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved What is the oral dose
Description
Proudly Made in the USA Our formula contains Magnesium in the form of Citrate for superior absorption

Modifiers GR, GU, and GE: Often used in teaching hospitals, residency applications, or medical testing situations to clarify the providers role or type of service offered

These are often missed in a quick check-up but are critical pieces of the puzzle

A used empty liquid laundry container is another viable option

Skin assessment, candid recommendation, no obligation
